Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
640.12B
Market cap640.12B
Price-Earnings ratio
30.78
Price-Earnings ratio30.78
Dividend yield
1.99%
Dividend yield1.99%
Average volume
6.17M
Average volume6.17M
High today
$270.39
High today$270.39
Low today
$265.25
Low today$265.25
Open price
$268.44
Open price$268.44
Volume
4.71M
Volume4.71M
52 Week high
$281.07
52 Week high$281.07
52 Week low
$173.33
52 Week low$173.33

Stock Snapshot

The current Johnson & Johnson(JNJ) stock price is $266.20, with a market capitalization of 640.12B. The stock trades at a price-to-earnings (P/E) ratio of 30.78 and offers a dividend yield of 1.99%.

During the trading session on 2026-09-12, Johnson & Johnson(JNJ) shares reached a daily high of $270.39 and a low of $265.25. At a current price of $266.20, the stock is +0.4% higher than the low and still -1.5% under the high.

Trading volume for Johnson & Johnson(JNJ) stock has reached 4.71M, versus its average volume of 6.17M.

Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $281.07 and a low of $173.33.

Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $281.07 and a low of $173.33.

JNJ News

Simply Wall St 1h
J&J Snack Foods Could Be 25% Below Fair Value As Growth Narrative Holds - simplywall.st

...

J&J Snack Foods Could Be 25% Below Fair Value As Growth Narrative Holds - simplywall.st
The Wall Street Journal 4h
J&J Is In Talks to Sell Its Hips-and-Knees Business to Apollo for $20 Billion

J&J has been seeking to unload its DePuy Synthes orthopedics business. Jeff Schear / Getty Images Private-equity firm Apollo Global Management is in talks to a...

J&J Is In Talks to Sell Its Hips-and-Knees Business to Apollo for $20 Billion
24/7 Wall St. 9h
The Closest Thing to Set-It-and-Forget-It Income: 5 Dividend Kings for Retirees Who Want Peace of Mind

Investing The Closest Thing to Set-It-and-Forget-It Income: 5 Dividend Kings for Retirees Who Want Peace of Mind Some companies have raised their dividends thro...

The Closest Thing to Set-It-and-Forget-It Income: 5 Dividend Kings for Retirees Who Want Peace of Mind

Analyst ratings

70%

of 27 ratings
Buy
70.4%
Hold
25.9%
Sell
3.7%

More JNJ News

24/7 Wall St. 12h
How Much Do You Really Need Invested in Dividend Stocks to Replace a $25,000 Income?

Investing How Much Do You Really Need Invested in Dividend Stocks to Replace a $25,000 Income? The math behind living off dividends exposes a brutal tradeoff: e...

How Much Do You Really Need Invested in Dividend Stocks to Replace a $25,000 Income?
Seeking Alpha 24h
Apollo in talks to acquire J&J’s orthopedics unit - Bloomberg

Apollo Global Management (APO) ​is in talks to acquire ‌Johnson & Johnson's (JNJ) DePuy Synthes orthopedics unit in a deal that could value it at close ​to $20B...

Apollo in talks to acquire J&J’s orthopedics unit - Bloomberg
TipRanks 1d
Apollo Global in discussions to buy JNJ’s orthopedics unit, Bloomberg reports

18:28 EDT Apollo Global (APO) in discussions to buy JNJ‘s orthopedics unit, Bloomberg reports Published first on TheFly – the ultimate source for real-time, ma...

24/7 Wall St. 1d
These 5 Dividend Stocks Survived 2008, COVID and Every Recession Before Them

Investing These 5 Dividend Stocks Survived 2008, COVID and Every Recession Before Them Chasing the fattest yield on the screen is a trap most income investors f...

These 5 Dividend Stocks Survived 2008, COVID and Every Recession Before Them
TipRanks 3d
Johnson & Johnson price target raised to $320 from $290 at HSBC

HSBC raised the firm’s price target on Johnson & Johnson to $320 from $290 and keeps a Buy rating on the shares. The firm adjusted targets in the healthcare gro...

Nasdaq 3d
Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage

Johnson & Johnson (NYSE:JNJ) MedTech Chairman Tim Schmid said the company remains confident it is delivering growth at the high end of its previously stated 5%...

Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage
Nasdaq 4d
Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?

Key Points iShares U.S. Pharmaceuticals ETF targets a specific subsector with 56 holdings, while iShares U.S. Healthcare ETF spans the broader industry with 10...

Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.